Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. t. u. ]. Rigoni-Stern (1945)One Hundred Years of Gynaecology
M. Bowden, J. Crawford, H. Cohen, O. Noyama (1993)A Comparative Study of Monoclonal Gammopathies and Immunoglobulin Levels in Japanese and United States Elderly
Journal of the American Geriatrics Society, 41
M. Lipkin, W. Blattner, J. Fraumeni, H. Lynch, E. Deschner, S. Winawer (1983)Tritiated Thymidine (φp,φh) Labeling Distribution as a Marker for Hereditary Predisposition to Colon Cancer
Cancer Research, 43
T. Mack, A. Paganini-Hill (1981)Epidemiology of pancreas cancer in Los Angeles
W. Haenszel (1971)Cancer mortality among U.S. Jews.
Israel journal of medical sciences, 7 12
P. Greenwald, R. Korns, P. Nasca, P. Wolfgang (1975)Cancer in United States Jews.
Cancer research, 35 11 Pt. 2
P. Watson, K. Lin, M. Rodriguez-Bigas, T. Smyrk, S. Lemon, M. Shashidharan, B. Franklin, Beth Karr, A. Thorson, H. Lynch (1998)Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members
J. Guillem, B. Rapaport, T. Kirchhoff, P. Kolachana, K. Nafa, E. Glogowski, R. Finch, Helen Huang, W. Foulkes, A. Markowitz, N. Ellis, K. Offit (2003)A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Journal of the American College of Surgeons, 196 2
J. Jass (1995)Colorectal adenoma progression and genetic change: is there a link?
Annals of medicine, 27 3
D. Dilworth, L. Liu, A. Stewart, J. Berenson, N. Lassam, D. Hogg (2000)Germline CDKN2A mutation implicated in predisposition to multiple myeloma.
Blood, 95 5
R. Kyle, Sidney Finkelstein, L. Elveback, L. Kurland (1972)Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma.
Blood, 40 5
H. Lynch, W. Kimberling, W. Albano, J. Lynch, Karen Biscone, G. Schuelke, A. Sandberg, M. Lipkin, E. Deschner, Y. Mikol, R. Elston, J. Bailey-Wilson, B. Danes (1985)Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). I. Clinical description of resource
J. Peters (1994)Familial cancer risk-Part II.Breast cancer risk counseling and genetic susceptiblity testing
J Oncol Manag, 3
J. Jass, T. Smyrk, S. Stewart, M. Lane, S. Lanspa, Henry Lynch (1994)Pathology of hereditary non-polyposis colorectal cancer.
Anticancer research, 14 4B
J. Potter (2003)Epidemiology, cancer genetics and microarrays: making correct inferences, using appropriate designs.
Trends in genetics : TIG, 19 12
Hai-Yan Yan, N. Papadopoulos, G. Marra, C. Perrera, J. Jiricny, C. Boland, H. Lynch, R. Chadwick, A. Chapelle, K. Berg, J. Eshleman, Weishi Yuan, S. Markowitz, S. Laken, C. Lengauer, K. Kinzler, B. Vogelstein (2000)Conversion of diploidy to haploidy - Individuals susceptible to multigene disorders may now be spotted more easily.
N. Terakawa, M. Hayashida, I. Shimizu, H. Ikegami, H. Wakimoto, T. Aono, O. Tanizawa, K. Matsumoto, M. Nishida (1987)Growth inhibition by progestins in a human endometrial cancer cell line with estrogen-independent progesterone receptors.
Cancer research, 47 7
H. Lynch, A. Krush, H. Guirgis (1973)Genetic factors in families with combined gastrointestinal and breast cancer.
The American journal of gastroenterology, 59 1
Y. Shoenfeld, S. Berliner, M. Shaklai, L. Gallant, J. Pinkhas (1982)Familial multiple myeloma. A review of thirty-seven families.
Postgraduate Medical Journal, 58
E. Peterson, K. Milliron, K. Lewis, Susan Goold, S. Merajver (2002)Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 11 1
A Hochman, E Ratzkowski, H Schreiber (1955)Incidence of carcinoma of the cervix in Israel
Br J Cancer, 9
Bethany Niell, J. Long, G. Rennert, S. Gruber (2003)Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.
American journal of human genetics, 73 6
HT Lynch, SJ Lemon, JN Marcus (1998)The Breast:Comprehensive Management of Benign and Malignant Diseases
G. Anday, B. Fishkin, E. Gabor (1974)Cytogenetic studies in multiple myeloma.
Journal of the National Cancer Institute, 52 4
O. Sieber, L. Lipton, M. Crabtree, K. Heinimann, P. Fidalgo, R. Phillips, M. Bisgaard, T. Orntoft, L. Aaltonen, S. Hodgson, H. Thomas, I. Tomlinson (2003)Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.
The New England journal of medicine, 348 9
H. Lynch, W. Sanger, S. Pirruccello, Brigid Quinn-Laquer, D. Weisenburger (2001)Familial multiple myeloma: a family study and review of the literature.
Journal of the National Cancer Institute, 93 19
H. Lynch, A. Krush (1971)Cancer family “G” revisited: 1895‐1970
J. Jass, S. Stewart (1992)Evolution of hereditary non-polyposis colorectal cancer.
R. Kyle, C. Heath, P. Carbone (1971)Multiple myeloma in spouses.
Archives of internal medicine, 127 5
R. Chen-Shtoyerman, L. Theodor, Ester Harmati, E. Friedman, Samir Dacka, Y. Kopelman, A. Sternberg, R. Zarivach, S. Bar‐Meir, Z. Fireman (2003)Genetic analysis of familial colorectal cancer in Israeli Arabs
Human Mutation, 21
H. Dyck, T. Hamilton, A. Godwin, H. Lynch, S. Maines-Bandiera, N. Auersperg (1996)Autonomy of the epithelial phenotype in human ovarian surface epithelium: Changes with neoplastic progression and with a family history of ovarian cancer
International Journal of Cancer, 69
S. Grufferman, E. Delzell (1984)Epidemiology of Hodgkin's disease.
Epidemiologic reviews, 6
H. King, E. Diamond, J. Bailar (1965)CANCER MORTALITY AND RELIGIOUS PREFERENCE: A SUGGESTED METHOD IN RESEARCH.
The Milbank Memorial Fund quarterly, 43
A. Hochman, E. Ratzkowski, H. Schreiber (1955)Incidence of Carcinoma of the Cervix in Jewish Women in Israel
British Journal of Cancer, 9
A. Warthin (1913)HEREDITY WITH REFERENCE TO CARCINOMA: AS SHOWN BY THE STUDY OF THE CASES EXAMINED IN THE PATHOLOGICAL LABORATORY OF THE UNIVERSITY OF MICHIGAN, 1895-1913
JAMA Internal Medicine, 12
M. Hammer, A. Redd, E. Wood, M. Bonner, H. Jarjanazi, T. Karafet, S. Santachiara-Benerecetti, A. Oppenheim, M. Jobling, T. Jenkins, H. Ostrer, B. Bonné-Tamir (2000)Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes.
Proceedings of the National Academy of Sciences of the United States of America, 97 12
S. Kullander (1987)Cancer Genetics in Women
Hoi‐Yan Yiu, A. Whittemore, A. Shibata (2004)Increasing colorectal cancer incidence rates in Japan
International Journal of Cancer, 109
Liora Strichman-Almashanu, S. Weltfriend, O. Gideoni, R. Friedman‐Birnbaum, S. Pollack (1995)No significant association between HLA antigens and classic kaposi sarcoma: Molecular analysis of 49 jewish patients
Journal of Clinical Immunology, 15
L. Kopelovich, S. Conlon, R. Pollack (1977)Defective organization of actin in cultured skin fibroblasts from patients with inherited adenocarcinoma.
Proceedings of the National Academy of Sciences of the United States of America, 74 7
HT Lynch, A. de la Chapelle (2003)Genomic medicine:hereditary colorectal cancer
N Engl J Med, 348
T. Mack, J. Berkel, L. Bernstein, W. Mack (1985)Religion and cancer in Los Angeles County.
National Cancer Institute monograph, 69
J. DiGiovanna, B. Safai (1981)Kaposi's sarcoma. Retrospective study of 90 cases with particular emphasis on the familial occurrence, ethnic background and prevalence of other diseases.
The American journal of medicine, 71 5
J. Hartmann, S. Fosså, Craig Nichols, J. Droz, A. Horwich, A. Gerl, J. Beyer, J. Pont, K. Fizazi, H. Hecker, L. Kanz, L. Einhorn, C. Bokemeyer (2001)Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Journal of the National Cancer Institute, 93 22
A. Eisen, T. Rebbeck, W. Wood, B. Weber (2000)Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 9
O. Díez, A. Osorio, Mercedes Robledo, A. Barroso, Montserrat Domènech, J. Cortés, J. Albertos, J. Sanz, Joan Brunet, J. SanRomán, A. Mc, Montserrat Baiget, Javier Benítez (1999)Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients
British Journal of Cancer, 79
Hai-Yan Yan, N. Papadopoulos, G. Marra, C. Perrera, J. Jiricny, C. Boland, Henry Lynch, R. Chadwick, A. Chapelle, K. Berg, J. Eshleman, Weishi Yuan, S. Markowitz, S. Laken, C. Lengauer, K. Kinzler, B. Vogelstein (2000)Conversion of diploidy to haploidy
M. MCCREA, MD MORRIS, MD Moms, Haematology Laboratory, G. Nelson, Dr. Henry, J. Robertson (1986)Concurrent familial myeloma in Northern Ireland
R. Doll (1978)An epidemiological perspective of the biology of cancer.
Cancer research, 38 11 Pt 1
J. Menczer (2003)The low incidence of cervical cancer in Jewish women: has the puzzle finally been solved?
The Israel Medical Association journal : IMAJ, 5 2
Lauren Scheuer, N. Kauff, M. Robson, B. Kelly, R. Barakat, J. Satagopan, N. Ellis, M. Hensley, J. Boyd, P. Borgen, L. Norton, K. Offit (2002)Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 5
H. Meijers-Heijboer, J. Wijnen, H. Vasen, Marijke Wasielewski, A. Wagner, A. Hollestelle, F. Elstrodt, R. Bos, Anja Snoo, Grace Fat, C. Brekelmans, S. Jagmohan, P. Franken, P. Verkuijlen, A. Ouweland, P. Chapman, C. Tops, G. Möslein, J. Burn, H. Lynch, J. Klijn, R. Fodde, M. Schutte (2003)The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype.
American journal of human genetics, 72 5
J. Risinger, J. Barrett, P. Watson, H. Lynch, J. Boyd (1996)Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome
S. Narod, J. Brunet, P. Ghadirian, M. Robson, K. Heimdal, S. Neuhausen, D. Stoppa-Lyonnet, C. Lerman, B. Pasini, P. Rios, B. Weber, H. Lynch (2000)Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study
The Lancet, 356
D. Shafritz, D. Shouval, H. Sherman, S. Hadziyannis, M. Kew (1981)Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.
The New England journal of medicine, 305 18
J Iscovich, P Boffetta, S Franceschi (2000)Classic kaposi sarcoma: epidemiology and risk factors
B. Vogelstein, K. Kinzler (1997)The Genetic Basis of Human Cancer
N. Kauff, Lauren Scheuer, M. Robson, E. Glogowski, B. Kelly, R. Barakat, A. Heerdt, P. Borgen, Jessica Davis, K. Offit (2001)Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations
Genetics in Medicine, 3
P Crozes-Bony, E Palazzo, O Meyer (1995)Familial multiple myeloma.Report of a case in a father and daughter.Review of the literature
Rev Rhum Engl Ed, 62
R. Bar-Sade, L. Theodor, E. Gak, A. Kruglikova, Galit Hirsch-Yechezkel, B. Modan, G. Kuperstein, U. Seligsohn, G. Rechavi, E. Friedman (1997)Could the 185 deIAG BRCA1 Mutation Be an Ancient Jewish Mutation?
European Journal of Human Genetics, 5
G. Rose, M. Dowsett, J. Mudge, J. White, S. Jeffcoate (1988)The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro.
Fertility and sterility, 49 2
P. Crozes-Bony, E. Palazzo, O. Meyer, M. Bandt, M. Kahn (1995)Familial multiple myeloma. Report of a case in a father and daughter. Review of the literature.
Revue du rhumatisme, 62 6
J. Peters (1994)Familial cancer risk-Part I:impact on today 's oncology practice
J Oncol Manag, 3
Y. Minami, Y. Tsubono, Y. Nishino, N. Ohuchi, Daisuke Shibuya, S. Hisamichi (2004)The increase of female breast cancer incidence in Japan: Emergence of birth cohort effect
International Journal of Cancer, 108
H. Lynch, T. Smyrk, T. Mcginn, S. Lanspa, J. Cavalieri, Jane Lynch, Susan Slominski‐Castor, M. Cayouette, I. Priluck, M. Luce (1995)Attenuated familial adenomatous polyposis (AFAP) a phenotypically and genotypically distinctive variant of FAP
Harold Stewart, Lucia Dunham, Julian Casper, Harold Dorn, Louis Thomas, John Edgcomb, Alexander Symeonidis (1966)Epidemiology of cancers of uterine cervix and corpus, breast and ovary in Israel and New York City.
Journal of the National Cancer Institute, 37 1
J. Jass, S. Stewart, J. Stewart, M. Lane (1994)Hereditary non-polyposis colorectal cancer--morphologies, genes and mutations.
Mutation research, 310 1
S. Gayther, J. Mangion, P. Russell, S. Seal, R. Barfoot, B. Ponder, M. Stratton, D. Easton (1997)Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene
Nature Genetics, 15
C. Oddoux, J. Struewing, C. Clayton, S. Neuhausen, L. Brody, M. Kaback, B. Haas, L. Norton, P. Borgen, S. Jhanwar, D. Goldgar, H. Ostrer, K. Offit (1996)The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%
Nature Genetics, 14
R. Segel, S. Silverstein, I. Lerer, E. Kahana, Rachel Meir, M. Sagi, N. Zilber, A. Korczyn, Y. Shapira, Z. Argov, D. Abeliovich (2003)Prevalence of myotonic dystrophy in Israeli Jewish communities: Inter‐community variation and founder premutations
American Journal of Medical Genetics Part A, 119A
HT. Lynch (1976)Cancer Genetics
AS. Warthin (1913)Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913
Arch Intern Med, 12
P. Roddie, R. Dang, A. Parker (1998)Multiple myeloma in three siblings.
Clinical and laboratory haematology, 20 3
Gareth Morgan, Faith Davies, M. Linet (2002)Myeloma aetiology and epidemiology.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 56 5
E. Hodak, M. Lapidoth, Y. Kohn, M. David, C. Brautbar, B. Kfir, R. Narinski, C. Safirman, L. Maron, T. Klein (2001)Mycosis fungoides: HLA class II associations among Ashkenazi and non‐Ashkenazi Jewish patients
British Journal of Dermatology, 145
J. Braithwaite (1901)EXCESS OF SALT IN THE DIET A PROBABLE FACTOR IN THE CAUSATION OF CANCER.1
The Lancet, 158
M. Hensley, M. Castiel, M. Robson (2000)Screening for ovarian cancer: what we know, what we need to know.
Oncology, 14 11
T. Rebbeck, T. Friebel, H. Lynch, S. Neuhausen, L. Veer, J. Garber, G. Evans, S. Narod, C. Isaacs, E. Matloff, M. Daly, O. Olopade, B. Weber (2004)Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 6
H. Lynch, S. Coronel, R. Okimoto, H. Hampel, K. Sweet, J. Lynch, Alicia Barrows, J. Wijnen, H. Klift, P. Franken, A. Wagner, R. Fodde, A. Chapelle (2004)A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
JAMA, 291 6
T. Rebbeck, H. Lynch, S. Neuhausen, S. Narod, L. Veer, J. Garber, G. Evans, C. Isaacs, M. Daly, E. Matloff, O. Olopade, B. Weber (2002)Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
The New England journal of medicine, 346 21
Michal Yaron, T. Levy, A. Chetrit, H. Levavi, G. Sabah, D. Schneider, R. Halperin, Z. Ben-Rafael, E. Friedman (2001)The polymorphic CAG repeat in the androgen receptor gene in Jewish Israeli women with endometrial carcinoma
Jose Iscovich, Paolo Boffetta, S. Franceschi, Esther Azizi, Ronit Sarid (2000)Classic Kaposi sarcoma
B. Modan, E. Gak, R. Sade-Bruchim, G. Hirsh-Yechezkel, L. Theodor, F. Lubin, G. Ben-Baruch, U. Beller, A. Fishman, R. Dgani, J. Menczer, M. Papa, E. Friedman (1996)High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel. National Israel Study of Ovarian Cancer.
JAMA, 276 22
JR. Jass (1995)Natural history of hereditary non-polyposis colorectal cancer
J Tumor Marker Oncol, 10
H. Lynch, G. Schuelke, W. Kimberling, W. Albano, J. Lynch, Karen Biscone, M. Lipkin, E. Deschner, Y. Mikol, A. Sandberg, R. Elston, J. Bailey-Wilson, B. Danes (1985)Hereditary nonpolyposis colorectal cancer (lynch syndromes I and II). II. Biomarker studies
F. Bosch, N. Muñoz, S. Sanjose (1997)Human papillomavirus and other risk factors for cervical cancer.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 51 6-7
P. Lynch, H. Lynch, Randall Harris (1977)Hereditary proximal colonic cancer
Diseases of the Colon & Rectum, 20
S. Berlin, H. Odeberg, L. Weingart (2009)Familial occurrence of M-components.
Acta medica Scandinavica, 183 4
R. Bar-Sade, A. Kruglikova, B. Modan, E. Gak, G. Hirsh-Yechezkel, L. Theodor, I. Novikov, R. Gershoni-baruch, S. Risel, M. Papa, G. Ben-Baruch, E. Friedman (1998)The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim.
Human molecular genetics, 7 5
H. Pfister (1996)The role of human papillomavirus in anogenital cancer.
Obstetrics and gynecology clinics of North America, 23 3
H. Deshpande, Xiaoping Hu, P. Marino, Naveed Jan, P. Wiernik (1998)Anticipation in familial plasma cell dyscrasias
British Journal of Haematology, 103
B. MacMahon (1960)The ethnic distribution of cancer mortality in New York City, 1955
Acta Un Int Contra Cancer, 16
PH Roddie, R Dang, AC. Parker (1998)Case report:multiple myeloma in three siblings
Clin Lab Haematol, 20
H. Lynch, A. Chapelle (1999)Genetic susceptibility to non-polyposis colorectal cancer
Journal of Medical Genetics, 36
H. Seidman (1970)Cancer death rates by site and sex for religious and socioeconomic groups in New York City.
Environmental research, 3 3
H. Lynch, S. Lanspa, B. Boman, T. Smyrk, P. Watson, J. Lynch, P. Lynch, G. Cristofaro, P. Bufo, A. Tauro, P. Mingazzini, E. DiGiulio (1988)Hereditary nonpolyposis colorectal cancer--Lynch syndromes I and II.
Gastroenterology clinics of North America, 17 4
Bernard Grosbois, P. Jego, Michel Attal, C. Payen, M. Rapp, Jean-Gabriel Fuzibet, Michel Maigre, Régis Bataille (1999)Familial multiple myeloma: report of fifteen families
British Journal of Haematology, 105
A. Jemal, Andrea Thomas, Taylor Murray, M. Thun (2002)Cancer Statistics, 2002
CA: A Cancer Journal for Clinicians, 52
L. Bernstein, P. Newton, R. Ross (1990)Epidemiology of hairy cell leukemia in Los Angeles County.
Cancer research, 50 12
M. Girardi, P. Heald, L. Wilson (2004)The pathogenesis of mycosis fungoides.
The New England journal of medicine, 350 19
L. Kopelovich (1982)Genetic predisposition to cancer in man: in vitro studies.
International review of cytology, 77
L. Hartmann, T. Sellers, D. Schaid, T. Frank, Cheryl Soderberg, Diana Sitta, M. Frost, C. Grant, J. Donohue, J. Woods, S. McDonnell, C. Vockley, A. Deffenbaugh, F. Couch, Robert Jenkins (2001)Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
Journal of the National Cancer Institute, 93 21
A. Wagner, Alicia Barrows, J. Wijnen, H. Klift, P. Franken, P. Verkuijlen, H. Nakagawa, M. Geugien, Shantie Jaghmohan-Changur, C. Breukel, H. Meijers-Heijboer, H. Morreau, M. Puijenbroek, J. Burn, S. Coronel, Yulia Kinarski, R. Okimoto, P. Watson, J. Lynch, A. Chapelle, H. Lynch, R. Fodde (2003)Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
American journal of human genetics, 72 5
A. de la Chapelle (2003)Microsatellite instability
N Engl J Med, 349
P. Watson, H. Lynch (1993)Extracolonic cancer in hereditary nonpolyposis colorectal cancer
Z. Zawadzki, Y. Aizawa, M. Kraj, A. Haradin, B. Fisher (1977)Familial immunopathies. Report of nine families and survey of literature
Williams Ed (1977)The epidemiology of thyroid cancer.
Annales de radiologie, 20
W. Foulkes, I. Thiffault, S. Gruber, M. Horwitz, N. Hamel, C. Lee, J. Shia, A. Markowitz, A. Figer, E. Friedman, D. Farber, C. Greenwood, J. Bonner, K. Nafa, T. Walsh, V. Marcus, L. Tomsho, J. Gebert, F. Macrae, C. Gaff, B. Paillerets, P. Gregersen, J. Weitzel, P. gordon, E. MacNamara, M. King, H. Hampel, A. Chapelle, J. Boyd, K. Offit, G. Rennert, G. Chong, N. Ellis (2002)The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
American journal of human genetics, 71 6
P. Rozen, H. Lynch, A. Figer, S. Rozen, Z. Fireman, C. Legum, L. Katz, A. Moy, W. Kimberling, Jane Lynch, P. Watson (1987)Familial colon cancer in the Tel‐Aviv area and the influence of ethnic origin
L. Mullineaux, T. Castellano, Jeffrey Shaw, L. Axell, M. Wood, S. Diab, C. Klein, M. Sitarik, A. Deffenbaugh, S. Graw (2003)Identification of germline 185delAG BRCA1 mutations in non‐Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado
W. Albano, J. Recabaren, H. Lynch, A. Campbell, J. Mailliard, C. Organ, J. Lynch, W. Kimberling (1982)Natural history of hereditary cancer of the breast and colon
B Modan, E Gak, RB Sade-Bruchim (1996)High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel
G. Feldman (2001)Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts.
The Israel Medical Association journal : IMAJ, 3 5
S. Leech, C. Bryan, R. Elston, J. Rainey, J. Bickers, M. Pelias (1983)Genetic studies in multiple myeloma 1. Association with HLA‐Cw5
G. Prodi, G. Nicoletti, C. Giovanni, M. Galli, S. Grilli, P. Nanni, G. Gola, R. Rocchetta, C. Orlandi (2004)Multiple steroid hormone receptors in normal and abnormal human endometrium
Journal of Cancer Research and Clinical Oncology, 98
Henry Lynch, J. Lynch, Wendy Rubinstein (2001)Prophylactic mastectomy: obstacles and benefits.
Journal of the National Cancer Institute, 93 21
L. Hartmann, A. Degnim, D. Schaid (2004)Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 6
J. Wagner, J. Tolar, O. Levran, T. Scholl, Amie Deffenbaugh, J. Satagopan, L. Ben-Porat, K. Mah, S. Batish, D. Kutler, M. MacMillan, H. Hanenberg, A. Auerbach (2004)Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.
Blood, 103 8
F. Bosch, M. Manos, N. Muñoz, M. Sherman, A. Jansen, J. Peto, M. Schiffman, V. Moreno, R. Kurman, K. Shah (1995)Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Journal of the National Cancer Institute, 87
EF Petricoin, AM Ardekani, BA Hitt (2002)Use of proteomic patterns in serum to identify ovarian cancer
H. Lynch, S. Lemon, C. Durham, S. Tinley, Chris Connolly, J. Lynch, Jonathan Surdam, Ernest Orinion, Sue Slominski‐Caster, P. Watson, C. Lerman, P. Tonin, Gilbert Lenoir, O. Serova, S. Narod (1997)A descriptive study of BRCA1 testing and reactions to disclosure of test results
M. Gutman, M. Inbar, J. Klausner, S. Chaitchik (1993)Malignant melanoma in different ethnic groups in Israel. Incidence and biologic behavior
L. Horwitz, R. Levy, F. Rosner (1985)Multiple myeloma in three siblings.
Archives of internal medicine, 145 8
H. Ludwig, W. Mayr (1982)Genetic aspects of susceptibility to multiple myeloma.
Blood, 59 6
J. Neulen, B. Wagner, M. Runge, M. Breckwoldt (2005)Effect of progestins, androgens, estrogens and antiestrogens on3H-thymidine uptake by human endometrial and endosalpinx cells in vitro
Archives of gynecology, 240
A. Balmain, J. Gray, B. Ponder (2003)The genetics and genomics of cancer
Nature Genetics, 33 Suppl 1
F. Bray, J. Ferlay, M. Laversanne, David Brewster, C. Mbalawa, B. Kohler, M. Piñeros, E. Steliarova-Foucher, Rajaraman Swaminathan, S. Antoni, Isabelle Soerjomataram, David Forman (1997)Cancer Incidence in Five Continents
H. Lynch, T. Smyrk (1996)Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma.
Gastroenterology, 110 3
H. Lynch, M. Shaw, M. Shaw, C. Magnuson, C. Magnuson, A. Larsen, A. Larsen, A. Krush, A. Krush (1966)Hereditary factors in cancer. Study of two large midwestern kindreds.
Archives of internal medicine, 117 2
R. Ross, J. Casagrande, R. Dworsky, A. Levine, T. Mack (1985)Kaposi's sarcoma in Los Angeles, California.
Journal of the National Cancer Institute, 75 6
J. Goedert, F. Vitale, Carmela Lauria, D. Serraino, M. Tamburini, M. Montella, A. Messina, E. Brown, G. Rezza, L. Gafà, N. Romano (2002)Risk factors for classical Kaposi's sarcoma.
Journal of the National Cancer Institute, 94 22
T. Smyrk, P. Watson, K. Kaul, H. Lynch (2001)Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma
Gillen Steiner, R. Kistner, J. Craig (1965)HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.
Metabolism: clinical and experimental, 14
M. Eriksson, B. Hallberg (2004)Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study
Cancer Causes & Control, 3
N. Bizzaro, P. Pasini (1990)Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings.
Haematologica, 75 1
H. Risch, J. McLaughlin, D. Cole, B. Rosen, L. Bradley, E. Kwan, E. Jack, D. Vesprini, G. Kuperstein, J. Abrahamson, I. Fan, B. Wong, S. Narod (2001)Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
American journal of human genetics, 68 3
L. Brown, M. Linet, R. Greenberg, D. Silverman, R. Hayes, G. Swanson, A. Schwartz, J. Schoenberg, L. Pottern, J. Fraumeni (1999)Multiple myeloma and family history of cancer among blacks and whites in the U.S.
F. Gagnon (1950)Contribution to the study of the etiology and prevention of cancer of the cervix of the uterus.
American journal of obstetrics and gynecology, 60 3
A. Jakubowska, R. Scott, J. Menkiszak, J. Gronwald, T. Byrski, T. Huzarski, B. Górski, C. Cybulski, Tadeusz Dbniak, E. Kowalska, T. Starzyńska, M. Ławniczak, S. Narod, J. Lubiński (2003)A high frequency of BRCA2 gene mutations in Polish families with ovarian and stomach cancer
European Journal of Human Genetics, 11
T. Rebbeck, A. Levin, A. Eisen, C. Snyder, P. Watson, L. Cannon-Albright, C. Isaacs, O. Olopade, J. Garber, A. Godwin, M. Daly, S. Narod, S. Neuhausen, H. Lynch, Barbara Weber (1999)Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Journal of the National Cancer Institute, 91 17
HT Lynch, K Lin, T Smyrk (1997)Colorectal cancer, pathology staging and survival in HNPCC
ASCO Program/Proceedings, 16
H. Lynch, P. Watson, S. Lanspa, J. Marcus, Thomas Smyrk, R. Fitzgibbons, M. Kriegler, J. Lynch (1988)Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II)
Diseases of the Colon & Rectum, 31
Katharina Meijers, B. Leeuw, Milena Voormolen-Kálova (1972)The multiple occurrence of myeloma and asymptomatic paraproteinaemia within one family.
Clinical and experimental immunology, 12 2
S. Arbel-Alon, J. Menczer, N. Feldman, M. Glezerman, L. Yeremin, E. Friedman (2002)Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women
International Journal of Gynecologic Cancer, 12
A. Chapelle, F. Wright (1998)Linkage disequilibrium mapping in isolated populations: the example of Finland revisited.
Proceedings of the National Academy of Sciences of the United States of America, 95 21
H. Lynch, A. Chapelle (2003)Hereditary colorectal cancer.
The New England journal of medicine, 348 10
T. Loth, A. Perrotta, J. Lima, R. Whiteaker, A. Robinson (1991)Genetic aspects of familial multiple myeloma.
Military medicine, 156 8
S. Preston‐Martin, H. Menck (1979)The epidemiology of thyroid cancer in Los Angeles county.
The Western journal of medicine, 131 5
M. Linet (1985)The Leukemias: Epidemiologic Aspects
MECHANISMS OF DISEASE Mechanisms of disease Use of proteomic patterns in serum to identify ovarian cancer
This article is based upon a literature overview of cancer in Jews. It involves a comparison of variation in incidence and prevalence rates between Jews and non-Jews. However, the reader must exercise a certain amount of skepticism when considering secular changes in cancer incidence and prevalence and the public health implications of such cancer variation. Ashkenazi Jews have a lifetime CRC risk of 9--15%. This elevated CRC risk is similar to that of individuals in the "familial risk" category, and differs strikingly from the 5–6% CRC risk for non-Ashkenazi members of general Western populations. A MedLine search tested the hypothesis that site-specific and/or all-cancer incidence and mortality rates are either higher or lower than expected in Ashkenazi Jews worldwide, when compared with reference populations. Results showed that all cancer incidence and mortality is not higher in Ashkenazi Jews when compared to North American non-Hispanic whites. Indeed, rates for some cancers, such as carcinoma of the lung in Ashkenazi males, are low; this example is likely attributable in large part to␣decreased tobacco use. Carcinoma of the ovary, pancreas, stomach, and non-Hodgkin's lymphoma have a higher incidence rate in Ashkenazi. Even though BRCA1 and BRCA2 founder mutations which predispose to carcinoma of the breast and ovary appear increased in Ashkenazi breast cancer affected women, there was no evidence supporting an elevated risk of breast cancer among Ashkenazi women. Our primary concern, however, is that Ashkenazi Jews may have one of the highest lifetime CRC risks of any ethnic group in the world, a risk that diverges significantly from that of the general population; therein, it logically calls for more intensive CRC screening guidelines. We have emphasized that the reader use caution in the interpretation of statistics which portray variation in incidence and prevalence figures for cancer in any racial, ethnic, or religious group, inclusive, of course, of Jews. Clearly, more research will be required in the interest of accuracy in the understanding of these cancer variations, since they portend the need for special cancer control strategies. A lesser degree of attention can then be given to carcinoma of the penis and uterine cervix, which occur very infrequently in Jews. We urge our colleagues to continue to probe further into these statistical differences in cancer's incidence and prevalence in order to garner a better understanding of cancer's etiology and pathogenesis.
Familial Cancer – Springer Journals
Published: Dec 30, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.